• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

Methyl (2S)-2-Amino-3-Cyclopropyl-Propanoate Hydrochloride: A Comprehensive Overview

Methyl (2S)-2-amino-3-cyclopropyl-propanoate hydrochloride, identified by the CAS number 206438-31-5, is a chiral compound with significant potential in the fields of pharmacology and organic synthesis. This compound is characterized by its unique stereochemistry, which plays a crucial role in its biological activity and therapeutic applications. Recent studies have highlighted its role in modulating cellular signaling pathways, particularly in the context of neurodegenerative diseases and cancer.

The structure of methyl (2S)-2-amino-3-cyclopropyl-propanoate hydrochloride consists of a central amino group attached to a chiral carbon, which is further connected to a cyclopropyl ring and a methyl ester group. The stereochemistry at the chiral center is critical for its biological activity, as it determines the compound's ability to interact with specific protein targets. Researchers have employed advanced computational methods, such as molecular docking and dynamics simulations, to elucidate the binding mechanisms of this compound with various enzymes and receptors.

Recent advancements in synthetic chemistry have enabled the efficient synthesis of methyl (2S)-2-amino-3-cyclopropyl-propanoate hydrochloride. One notable approach involves the use of asymmetric catalysis to achieve high enantiomeric excess during the formation of the chiral center. This method not only enhances the yield but also ensures the purity of the final product, which is essential for subsequent biological testing.

In terms of pharmacological applications, methyl (2S)-2-amino-3-cyclopropyl-propanoate hydrochloride has shown promising results in preclinical studies targeting neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The compound has been found to inhibit key enzymes involved in amyloid-beta production and tau phosphorylation, two hallmark processes in these conditions. Additionally, its ability to cross the blood-brain barrier makes it a potential candidate for central nervous system therapeutics.

Another area of interest for methyl (2S)-2-amino-3-cyclopropyl-propanoate hydrochloride is its role in anticancer therapy. Recent research has demonstrated its potential to induce apoptosis in various cancer cell lines by modulating mitochondrial function and activating caspase pathways. Furthermore, studies have explored its combination with conventional chemotherapeutic agents to enhance efficacy while reducing systemic toxicity.

The stability and bioavailability of methyl (2S)-2-amino-3-cyclopropyl-propanoate hydrochloride are critical factors influencing its therapeutic potential. In vitro studies have shown that the compound exhibits moderate stability under physiological conditions, with a half-life sufficient for sustained drug delivery. Efforts are ongoing to optimize its formulation to improve absorption and reduce degradation during gastrointestinal transit.

In conclusion, methyl (2S)-2-amino-3-cyclopropyl-propanoate hydrochloride represents a promising compound with diverse applications in drug discovery and development. Its unique structure, coupled with advancements in synthetic and pharmacological research, positions it as a valuable tool in addressing unmet medical needs across multiple therapeutic areas.

• 5845-53-4((R)-Methyl 2-amino-4-methylpentanoate hydrochloride)
• 535936-86-8(Methyl 2-amino-2-cyclopropylacetate hydrochloride)
• 17193-39-4((S)-Methyl 2-amino-3-cyclohexylpropanoate hydrochloride)
• 8002-72-0(Onion oil)
• 144644-00-8(3-Cyclohexyl-d-alanine Methyl Ester Hydrochloride)
• 18598-74-8(H-Ile-OMe.HCl)
• 7517-19-3(H-Leu-OMe.HCl)
• 6322-53-8(H-DL-Leu-OMe Hydrochloride)
• 499158-69-9(Cycloheptanepropanoic acid, a-amino-, methyl ester, hydrochloride)
• 138326-68-8((S)-Methyl 2-amino-2-cyclopropylacetate hydrochloride)